OakChart

Sarepta Therapeutics Inc

SRPTHealthcare·Biotechnology·USA·Small·NASD·Nov 11 • 3:59 PM ET

16.68+0.26 (1.58%)
2026-11-12 04:08 CET
Market cap
1,788.70 USD m
Revenue, TTM
1,956.34 USD m
Net income, TTM
-114.62 USD m
Free cash flow, TTM
172.12 USD m
EPS diluted, TTM
-1.37
P/E
-
Compare

Price

SRPT against its 20, 50 and 200-day averages
2050200miss
15.0017.5020.0022.5010.0M20.0MVolumeMay 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26SRPTclose 16.6820-day 18.0950-day 18.87200-day 18.5716.6852w low

32.4% under the 52-week high of 24.68 on 26 Jan 2026. 52-week low 14.68 on 11 Jun 2026. Last 15 sessions, 21.9% high to low

Volume 0.75× normal · the line is the 50-bar volume average

Profile

SRPT
52-week range, 20% of the way up
14.6824.68

Sarepta Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which is engaged in the discovery and development of therapeutics for the treatment of rare diseases. The company was founded on July 22, 1980 and is headquartered in Cambridge, MA.

IndexRUT
Employees835
IPOJun 04, 1997
Beta0.47
ATR, 14d0.99
Rel volume0.75
Short float18.92%
Insider own4.91%
Inst own101.93%

Snapshot

6 groups

Valuation

IndexRUT
Market Cap1.79B
Enterprise Value1.96B
Income-114.62M
Sales1.96B
Book/sh14.26
Cash/sh8.19
Dividend Est.-
Dividend TTM-
Dividend Ex-Date-
Dividend Gr. 3/5Y- -
Payout-
Employees835
IPOJun 04, 1997

Ratios

P/E-
Forward P/E113.60
PEG-
P/S0.91
P/B1.17
P/C2.04
P/FCF10.39
EV/EBITDA48.03
EV/Sales1.00
Quick Ratio2.13
Current Ratio3.46
Debt/Eq0.69
LT Debt/Eq0.59
Option/ShortYes / Yes

Earnings

EPS (ttm)-1.37
EPS next Y0.15
EPS next Q-0.35
EPS this Y136.33%
EPS next Y-94.33%
EPS next 5Y-
EPS past 3/5Y3.92% -0.05%
Sales past 3/5Y33.06% 32.41%
EPS Y/Y TTM59.85%
Sales Y/Y TTM-18.95%
EPS Q/Q85.03%
Sales Q/Q-4.51%
EarningsNov 05 AMC
EPS/Sales Surpr.-441.77% 8.28%

Ownership

Insider Own4.91%
Insider Trans0.00%
Inst Own101.93%
Inst Trans2.29%
ROA-3.44%
ROE-8.05%
ROIC-4.73%
Gross Margin54.90%
Oper. Margin-0.43%
Profit Margin-5.86%
SMA20-7.81%
SMA50-11.61%
SMA200-10.16%
Trades-

Technical

Shs Outstand107.23M
Shs Float101.97M
Short Float18.92%
Short Ratio7.00
Short Interest19.30M
52W High24.68 -32.41%
52W Low14.68 13.62%
Volatility6.92% 5.59%
ATR (14)0.99
RSI (14)40.30
Beta0.47
Rel Volume0.75
Avg Volume2.76M
Volume2,056,100

Performance

Perf Week-12.16%
Perf Month1.03%
Perf Quarter-9.45%
Perf Half Y-11.46%
Perf YTD-22.49%
Perf Year-7.23%
Perf 3Y-79.01%
Perf 5Y-80.63%
Perf 10Y-57.79%
Recom2.67
Target Price21.77
Prev Close16.42
Price16.68
Change %1.58%

Analyst ratings

latest 10 of 20
DateActionAnalystRating changeTargetImplied
Nov 10, 2026UpgradeDDeutsche BankSell → Hold$14 → $18+7.9%
Jul 09, 2026UpgradeWWolfe ResearchPeer Perform → Outperform$27+61.9%
Jan 28, 2026ResumedBBarclaysEqual Weight$20+19.9%
Dec 09, 2025InitiatedWWedbushOutperform$32+91.8%
Nov 05, 2025UpgradeMMizuhoNeutral → Outperform$26+55.9%
Sep 22, 2025UpgradeBBMO Capital MarketsMarket Perform → Outperform$50+199.8%
Jul 29, 2025UpgradeOOppenheimerPerform → Outperform$37+121.8%
Jul 29, 2025UpgradeJJP MorganUnderweight → Neutral$24+43.9%
Jul 29, 2025UpgradeBBarclaysUnderweight → Equal Weight$22+31.9%
Jul 29, 2025ReiteratedHH.C. WainwrightSell$5-70.0%

Peers

Mkt cap
TickerCompanyMkt cap
DYNDyne Therapeutics Inc3.37B
WVEWave Life Sciences Inc674.52M
SLDBSolid Biosciences Inc848.24M
RGNXRegenxbio Inc560.06M
EWTXEdgewise Therapeutics Inc5.21B
PTCTPTC Therapeutics Inc5.42B
CAPRCapricor Therapeutics Inc652.32M
RAREUltragenyx Pharmaceutical Inc1.70B
PEPGPepGen Inc364.31M
SRRKScholar Rock Holding Corp5.68B

Insider trading

7 filings
InsiderRelationshipDateTransactionCostSharesValueTotal heldForm
Mayo StephenDirectorMar 12 '26Sale17.027,239123,2081,765Mar 13 08:03 PM
STEPHEN MAYODirectorMar 12 '26Proposed Sale17.027,239123,175Mar 12 04:27 PM
Estepan Ian MichaelChief Operating OfficerFeb 26 '26Option Exercise13.717,450102,140200,750Mar 02 08:00 AM
Nicaise ClaudeDirectorJan 29 '26Option Exercise13.7110,500143,95538,312Jan 29 08:05 PM
BEHRENS M KATHLEENDirectorJan 27 '26Option Exercise13.7110,500143,955203,976Jan 29 08:04 PM
Estepan Ian MichaelChief Operating OfficerDec 16 '25Sale22.3113,187294,202193,300Dec 18 08:05 PM
IAN M ESTEPANOfficerDec 16 '25Proposed Sale22.3113,187294,145Dec 16 05:05 PM

Held by

AUM
TickerCompanyAUM
IJRiShares Core S&P Small-Cap ETFAUM: 106.27B
VTIVanguard Morningstar Total Stock Market ETFAUM: 687.42B
XBIState Street SPDR S&P Biotech ETFAUM: 10.50B
IWMiShares Russell 2000 Index FundAUM: 77.38B
VBVanguard Morningstar Small-Cap ETFAUM: 79.59B
VBKVanguard Morningstar Small-Cap Growth ETFAUM: 22.34B
VXFVanguard Extended Market Index ETFAUM: 30.47B
SPSMState Street SPDR Portfolio S&P 600TM Small Cap ETFAUM: 16.06B
IWNiShares Russell 2000 Value ETFAUM: 14.10B
IBBiShares Biotechnology ETFAUM: 11.36B

News

latest 14 of 200

Quarterly earnings

actual against estimate
PeriodReportedEPS actEPS estEPS repSales actSales estAnalysts
2026Q32026-11-05-0.2700.079-0.270381.35352.1819
2026Q22026-08-05-0.0500.217-0.046401.25366.3919
2026Q12026-05-062.8800.9762.878730.8474.1621
2025Q42026-02-25-3.930-1.197-3.934442.93369.622
2025Q32025-11-03-1.800-0.727-1.795399.36335.7622
2025Q22025-08-061.8900.8321.887611.09530.6624
2025Q12025-05-06-4.600-3.207-4.596744.86687.4713
2024Q42025-02-261.5001.8831.612658.41627.5918
2024Q32024-11-060.340-0.0760.339467.17407.1717
2024Q22024-08-070.070-0.1300.068362.93394.389
2024Q12024-05-010.3700.0130.364413.46379.5217
2023Q42024-02-280.4700.0690.432396.78387.1818
2023Q32023-11-01-0.460-1.223-0.461331.82285.3316
2023Q22023-08-02-0.270-1.777-0.270261.24255.9913
2023Q12023-05-02-5.860-1.298-5.860253.5241.9617
2022Q42023-02-28-1.240-1.474-1.244258.43250.410

Annual earnings

PeriodEPS actEPS estEPS repSales actSales est
2019FY-9.710-7.973-9.714380.83379.23
2020FY-7.110-6.545-7.108540.1540.17
2021FY-5.150-5.109-5.153701.89695.42
2022FY-8.030-8.063-8.034933.01924.7
2023FY-5.800-6.573-5.8011,2431,233
2024FY2.1812.6152.3381,9021,848
2025FY-7.130-4.894-7.1302,1981,860
2026FY-2.590--1,864
2027FY-0.147--1,407
2028FY-0.005--1,357
2029FY--0.336--1,236
2030FY--0.352--1,192

Estimate revisions

last 14 periods
PeriodTypeDateEstimatesUpDownMeanLowHigh
2026Q4S2026-11-092094354.17300.77389.23
2026Q4S2026-11-062093354.88300.77389.23
2026Q4S2026-11-052013351.36327.1389.23
2026Q4S2026-10-262013351.35327389.23
2026Q4S2026-10-202013351.35327389.23
2026Q4S2026-10-1320215351.98327391.5
2026Q4S2026-10-0920215352.67327391.5
2026Q4S2026-10-0620215352.99327391.5
2026Q4S2026-09-2520215353.48327391.5
2026Q4S2026-09-1419215353.88327391.5
2026Q4S2026-09-0820216353.68327391.5
2026Q4S2026-09-0720216353.68327391.5
2026Q4S2026-08-2720216353.68327391.5
2026Q4S2026-08-2620216353.67327391.5

Estimate history

EPS, annual-0.86-5.463-9.714-7.108-5.153-8.034-5.8012.338-7.126-1.3709
Period201720182019202020212022202320242025TTM
EPS, quarterly0.3391.612-4.5961.887-1.795-3.9342.878-0.046-0.269
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Sales, annual154.584301.034380.833540.099701.887933.0131243.3361901.9792198.2371956.34
Period201720182019202020212022202320242025TTM
Sales, quarterly467.172658.412744.856611.091399.356442.934730.803401.251381.351
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Shares, annual64.79271.07275.18579.37487.12787.9593.73296.9104.964107.233
Period201720182019202020212022202320242025MRQ
Shares, quarterly95.49396.998.25597.706104.768104.964105.571105.624107.233
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Income statement, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Total Revenue1,956.342,198.241,901.981,243.34933.01701.89540.10380.83301.03
Cost of Goods Sold Incl. D&A882.40884.13356.82194.74181.85135.0790.2957.4435.06
Gross Profit1,073.931,314.111,545.161,048.60751.16566.82449.81323.40265.98
Selling, General and Administrative Excl. Other1,082.341,971.881,327.081,316.421,281.361,016.031,013.87845.52607.93
Research and Development647.261,492.95778.47844.38839.38743.39704.19560.71397.94
Other Operating Expense0.000.000.000.000.000.000.000.000.00
Operating Income-8.40-657.77218.08-267.82-530.20-449.21-564.06-522.12-341.95
Interest Expense85.6838.1418.3922.0153.2563.5259.9530.6733.71
Unusual Expense41.1825.157.84418.85127.327.7945.10183.444.00
Net Income Before Taxes-92.02-702.23260.77-520.10-689.96-418.95-553.07-713.88-362.61
Income Taxes22.6011.1925.5415.8813.53-0.171.061.20-0.69
Consolidated Net Income-114.62-713.41235.24-535.98-703.49-418.78-554.13-715.08-361.92
Net Income From Continuing Operations-114.62-713.41235.24-535.98-703.49-418.78-554.13-715.08-361.92
Net Income-114.62-713.41235.24-535.98-703.49-418.78-554.13-715.08-361.92
EPS (Recurring)-0.62-6.952.39-2.63-7.02-5.09-6.70-7.97-5.42
EPS (Basic, Before Extraordinaries)-1.10-7.132.47-5.80-8.03-5.15-7.11-9.71-5.46
EPS (Diluted)-1.37-7.132.34-5.80-8.03-5.15-7.11-9.71-5.46
EBITDA40.87-599.30271.97-208.93-475.60-399.87-524.32-491.58-329.70
Non-Operating Income (Expense)43.2518.8368.92188.5920.80101.58116.0522.3517.05
Other After Tax Adjustments0.000.000.000.000.000.000.000.000.00
Stock Option Compensation Expense87.4097.48145.60144.19184.0883.1878.8957.3839.60
Price To Earnings Ratio--101.01------
Price To Sales Ratio0.990.986.907.1712.1610.4324.6124.9424.02
Gross Margin54.9059.7881.2484.3480.5180.7683.2884.9288.35
Operating Margin-0.43-29.9211.47-21.54-56.83-64.00-104.44-137.10-113.59
Net Margin-5.86-32.4512.37-43.11-75.40-59.66-102.60-187.77-120.22
Shares Outstanding107.23104.9696.9093.7387.9587.1379.3775.1871.07
Market Capitalization1,788.701,788.7011,614.249,020.7111,374.877,841.2713,453.889,619.037,694.76

Income statement, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q22025Q12024Q4
Total Revenue381.35401.25730.80442.93399.36611.09744.86658.41
Cost of Goods Sold Incl. D&A194.41159.79119.36408.84169.22163.40147.54142.76
Gross Profit186.94241.46611.4434.10230.13447.69597.31515.65
Selling, General and Administrative Excl. Other195.98189.17253.01444.18293.01332.12897.70353.97
Research and Development82.5591.26153.96319.50218.89204.39773.45192.60
Other Operating Expense0.000.000.000.000.000.000.000.00
Operating Income-9.0452.29358.43-410.08-62.88115.58-300.39161.68
Interest Expense21.6221.5121.7120.847.575.234.504.47
Unusual Expense0.5239.451.71-0.50131.28-36.7290.73-0.73
Net Income Before Taxes-25.77-1.75343.17-407.68-194.05153.64-383.52171.74
Income Taxes2.693.1412.214.55-14.10-43.2563.9912.69
Consolidated Net Income-28.46-4.89330.96-412.23-179.95196.89-447.51159.05
Net Income From Continuing Operations-28.46-4.89330.96-412.23-179.95196.89-447.51159.05
Net Income-28.46-4.89330.96-412.23-179.95196.89-447.51159.05
EPS (Recurring)-0.270.222.89-3.94-0.881.65-3.941.61
EPS (Basic, Before Extraordinaries)-0.27-0.053.15-3.93-1.802.01-4.601.65
EPS (Diluted)-0.27-0.052.88-3.93-1.801.89-4.601.61
EBITDA0.1565.91372.14-397.33-41.06130.44-286.47176.01
Non-Operating Income (Expense)5.416.928.1722.757.686.5712.1013.81
Other After Tax Adjustments0.000.000.000.000.000.000.000.00
Stock Option Compensation Expense21.1319.3323.2323.7111.7929.2532.7339.24
Price To Earnings Ratio------26.78101.01
Price To Sales Ratio0.990.961.211.030.800.732.786.93
Gross Margin49.0260.1883.677.7057.6373.2680.1978.32
Operating Margin-2.3713.0349.05-92.58-15.7518.91-40.3324.56
Net Margin-7.46-1.2245.29-93.07-45.0632.22-60.0824.16
Shares Outstanding107.23105.62105.57104.96104.7797.7198.2596.90
Market Capitalization1,788.701,897.202,284.582,255.021,882.941,680.546,192.5911,614.24

Balance sheet, annual

Currency USD, millions
Metric2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY
Cash & Short Term Investments939.651,354.791,676.251,989.372,115.871,938.571,124.751,173.911,079.06
Short Term Receivables519.61649.73439.71259.70171.64138.5893.9464.4429.47
Inventories914.74749.96322.86203.97186.21231.96171.38125.4483.61
Other Current Assets163.93318.98140.52104.82130.38176.0878.8562.3936.51
Total Current Assets2,537.943,073.462,579.332,557.862,604.102,485.201,468.911,426.181,228.64
Net Property, Plant & Equipment470.62488.65357.11244.99236.69282.19167.5597.0243.16
Total Investments and Advances23.69152.4522.1150.3444.8048.1141.5032.7410.76
Intangible Assets28.9526.8929.627.5814.2413.6312.5011.5714.36
Deferred Tax Assets2.82--------
Other Assets285.68221.72276.41267.59248.15155.59132.3674.5511.04
Total Assets3,349.703,963.173,264.583,128.373,147.972,984.721,822.821,642.081,307.96
Short Term Debt Incl. Current Port. of LT Debt11.2013.27123.3315.4915.0520.937.850.006.17
Accounts Payable280.84214.44164.9295.8876.74111.0968.0933.838.47
Income Tax Payable4.7517.3913.7712.52---0.300.94
Other Current Liabilities798.50486.58351.65495.72360.94284.01188.83139.5672.75
Total Current Liabilities1,095.29731.68653.66619.60452.73416.03264.77173.6988.33
Long Term Debt1,028.351,329.601,273.481,601.871,138.391,072.86729.62420.55424.88
Provision for Risks Charges0.000.000.000.000.000.000.000.000.00
Other Liabilities85.44374.15478.10521.94628.84734.0710.2515.555.54
Total Liabilities2,209.082,435.432,405.242,743.422,219.972,222.961,004.63609.80518.75
Non-Equity Reserves0.000.000.000.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.000.000.000.00
Common Equity1,140.621,527.74859.34384.95928.01761.76818.191,032.28789.22
Total Shareholders Equity1,140.621,527.74859.34384.95928.01761.76818.191,032.28789.22
Accumulated Minority Interest0.000.000.000.000.000.000.000.000.00
Total Equity1,140.621,527.74859.34384.95928.01761.76818.191,032.28789.22
Total Liabilities & Stockholders Equity3,349.703,963.173,264.583,128.373,147.972,984.721,822.821,642.081,307.96
Book Value Per Share10.8715.779.174.3810.659.6010.8814.5212.18
Tangible Book Value Per Share10.5915.498.854.2910.499.4310.7214.3611.96
Full-Time Employees8351,3721,3141,162840866743499255
Price to Book Ratio1.179.5111.8026.408.4517.7611.867.515.15
Return on Assets-19.516.51-16.77-22.42-13.66-23.05-41.28-24.54-5.85
Return on Equity-53.4719.71-86.15-107.16-49.57-70.15-77.29-39.74-9.00
Return on Invested Capital-32.898.23-25.13-35.41-20.27-30.20-46.20-24.91-4.17
Quick Ratio1.483.183.453.805.345.424.907.4912.96
Current Ratio2.324.203.954.135.755.975.558.2113.91

Cash flow, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Net Income14.76-713.41235.24-535.98-703.49-418.78-554.13-715.08-361.92
Depreciation44.4058.4753.8958.8954.6038.0226.9130.5512.24
Other Funds (Non Cash)185.13354.36221.69457.18363.0135.7680.63290.6168.91
Funds from Operations244.29-300.58510.82-19.90-285.88-345.01-446.59-393.92-280.77
Extraordinary Item0.000.000.000.000.000.000.000.000.00
Changes in Working Capital-63.0078.04-716.61-481.09-39.47-98.17554.06-66.88-107.89
Cash from Operating Activities181.29-222.54-205.79-500.99-325.35-443.17107.47-460.80-388.66
Capital Expenditures-13.50-109.85-146.96-87.34-30.82-38.49-85.70-62.71-64.34
Net Assets From Acquisitions0.000.000.000.000.000.000.00-172.560.00
Sale of Fixed Assets and Businesses0.000.000.000.000.000.000.000.00-
Purchase or Sale of Investments-276.41179.49902.52-180.46-1,013.63436.01-144.09521.99-306.14
Purchase of Investments-557.30-290.48-1,099.60-2,048.94-1,936.86-29.99-1,333.57-1,193.63-1,171.96
Sale Or Maturity of Investments280.89469.972,002.111,868.48923.22466.001,189.481,715.63865.81
Other Uses0.000.000.000.00-2.43-4.110.000.000.00
Other Sources0.000.000.00102.000.00102.00108.070.000.00
Cash from Investing Activities-289.9169.64755.56-165.80-1,046.88495.41-121.72286.73-370.49
Cash Dividends Paid0.000.000.000.000.000.000.000.000.00
Change in Capital Stock0.4411.3079.5351.2530.04569.33396.01401.95563.63
Repurchase of Common Pref Stock0.00-25.010.000.000.000.000.000.000.00
Sale of Common Pref Stock0.4436.3279.5351.2530.04569.33396.01401.95563.63
Proceedsfrom Stock Options-0.1117.610.000.000.00548.53312.05401.95513.41
Issuance or Reduction of Debt, Net-35.13-162.5945.2873.76202.460.00291.11244.94-31.35
Change in Long Term Debt-35.13-162.5945.2873.76202.460.00291.11244.94-31.35
Issuance of Long Term Debt425.000.0045.3573.761,153.000.00291.11244.94235.87
Reduction of Long Term Debt-460.13-162.59-0.070.00-950.540.000.000.00-267.22
Net Financing Active Other Cash Flow0.000.000.000.000.00-7.76-4.800.00-2.13
Other Financing Activities Uses0.000.000.000.000.00-7.76-4.800.00-2.13
Cash from Financing Activities-34.69-151.28124.81125.00232.51561.57682.32646.89530.15
Net Change in Cash-143.32-304.18674.58-541.79-1,139.72613.81668.07472.82-229.00
Free Cash Flow172.12-324.51-342.74-577.10-356.17-481.6625.26-520.43-449.82
Preferred Dividends (Cash Flow)-0.000.000.000.000.000.000.000.00
Price to Free Cash Flow11.21-----526.07--
Deferred Taxes & Investment Tax Credit-0.000.000.000.000.000.000.000.00

Balance sheet, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q2
Cash & Short Term Investments878.78788.49653.19939.65850.99800.14
Short Term Receivables427.48438.81547.91519.61541.60609.60
Inventories876.12904.271,001.11914.741,077.17994.04
Other Current Assets90.5292.25107.66163.93248.25253.22
Total Current Assets2,272.892,223.822,309.882,537.942,718.022,656.99
Net Property, Plant & Equipment437.00446.84460.30470.62498.10514.90
Total Investments and Advances125.76162.84102.8623.6922.33245.71
Intangible Assets29.8330.6131.3828.9529.6830.52
Deferred Tax Assets2.852.862.812.822.27-
Other Assets297.73321.53271.71285.68223.03231.70
Total Assets3,166.073,188.513,178.933,349.703,493.443,679.81
Short Term Debt Incl. Current Port. of LT Debt157.970.000.0011.200.000.00
Accounts Payable45.7050.9870.38280.8494.02136.70
Income Tax Payable10.229.3113.794.759.0918.73
Other Current Liabilities442.46442.62415.00798.50818.32764.52
Total Current Liabilities656.35502.91499.161,095.29921.42919.95
Long Term Debt895.061,045.851,036.671,028.351,250.191,353.88
Provision for Risks Charges0.000.000.000.000.000.00
Other Liabilities85.80111.96138.0085.441.7048.60
Total Liabilities1,637.211,660.711,673.832,209.082,173.322,322.43
Non-Equity Reserves0.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.00
Common Equity1,528.851,527.801,505.101,140.621,320.121,357.38
Total Shareholders Equity1,528.851,527.801,505.101,140.621,320.121,357.38
Accumulated Minority Interest0.000.000.000.000.000.00
Total Equity1,528.851,527.801,505.101,140.621,320.121,357.38
Total Liabilities & Stockholders Equity3,166.073,188.513,178.933,349.703,493.443,679.81
Book Value Per Share14.2614.4614.2610.8712.6013.89
Tangible Book Value Per Share13.9814.1713.9610.5912.3213.58
Full-Time Employees---835--
Price to Book Ratio1.171.262.001.711.391.47
Return on Assets-3.44-7.75-1.94-23.05-7.66-1.63
Return on Equity-8.05-18.45-4.86-63.17-21.37-4.76
Return on Invested Capital-1.17-0.1913.02-19.01-7.007.26
Quick Ratio2.132.622.621.481.781.81
Current Ratio3.464.424.632.322.952.89

Cash flow, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q2
Net Income-28.46-4.89330.96-282.85-179.95196.89
Depreciation9.1913.6213.707.8821.8214.86
Other Funds (Non Cash)38.8345.0038.9162.39159.980.05
Funds from Operations19.5753.73383.57-212.581.86211.80
Extraordinary Item0.000.000.000.000.000.00
Changes in Working Capital40.40143.34-586.25339.51-29.2349.53
Cash from Operating Activities59.97197.07-202.68126.93-27.37261.34
Capital Expenditures-6.13-0.56-3.08-3.73-28.25-31.98
Net Assets From Acquisitions0.000.000.000.000.000.00
Sale of Fixed Assets and Businesses0.000.000.000.000.000.00
Purchase or Sale of Investments-152.22-92.82-131.3199.94260.6564.19
Purchase of Investments-206.25-180.85-170.200.000.00-4.43
Sale Or Maturity of Investments54.0388.0338.8999.94260.6568.63
Other Uses0.000.000.000.000.000.00
Other Sources0.000.000.000.000.000.00
Cash from Investing Activities-158.35-93.37-134.3996.21232.4032.21
Cash Dividends Paid0.000.000.000.000.000.00
Preferred Dividends (Cash Flow)0.000.000.000.000.000.00
Change in Capital Stock0.000.000.240.2018.94-23.51
Repurchase of Common Pref Stock0.000.000.000.000.00-25.01
Sale of Common Pref Stock0.000.000.240.2018.941.50
Proceedsfrom Stock Options0.000.000.00-0.1117.720.00
Issuance or Reduction of Debt, Net0.000.000.00-35.13-123.94-0.30
Change in Long Term Debt0.000.000.00-35.13-123.94-0.30
Issuance of Long Term Debt0.00175.00250.000.000.000.00
Reduction of Long Term Debt0.00-175.00-250.00-35.13-123.94-0.30
Net Financing Active Other Cash Flow0.000.000.000.000.000.00
Other Financing Activities Uses0.000.000.000.000.000.00
Cash from Financing Activities0.000.000.24-34.94-105.00-23.82
Net Change in Cash-98.39103.70-336.83188.21100.03269.73
Free Cash Flow57.03196.51-204.76123.34-50.31229.54
Price to Free Cash Flow11.2129.2427.12---

Revenue breakdown

ELEVIDYS2024: 820.79M 2025: 898.73M
PMO Products2024: 967.17M 2025: 965.57M
Non-US2024: 150.25M 2025: 165.18M
United States2024: 1.64B 2025: 1.70B

Short interest

shares short against float, oldest to newest
SettlementOf floatShares shortFloatAvg volume
2026-10-3018.92%19.3M102.0M2.91M
2026-10-1522.23%22.3M100.4M3.02M
2026-09-3022.68%22.8M100.4M3.03M
2026-09-1525.32%25.4M100.4M3.41M
2026-08-3124.38%24.6M101.0M3.34M
2026-08-1426.79%27.0M101.0M3.33M
2026-07-3127.30%27.6M101.0M3.39M
2026-07-1528.23%28.5M100.9M3.30M
2026-06-3028.47%28.7M100.9M3.14M
2026-06-1525.04%25.2M100.5M3.05M
2026-05-2924.83%25.1M101.2M3.02M
2026-05-1524.72%25.0M101.2M2.97M
2026-04-3024.92%24.9M100.0M2.78M
2026-04-1525.47%25.3M99.5M2.85M
2026-03-3125.87%25.7M99.4M3.02M
2026-03-1323.02%22.9M99.4M2.73M
2026-02-2721.36%21.2M99.4M2.83M
2026-02-1322.37%22.2M99.3M3.13M
2026-01-3022.53%22.2M98.6M4.05M
2026-01-1521.57%21.3M98.6M4.20M

Option chain

expiry 2026-11-13
TypeStrikeBidAskLastIVOpen intVolumeDeltaThetaVega
call7.007.6011.609.2918.5091.000.000.984-0.0820.000
call8.006.609.707.4412.10217.002.000.981-0.0810.001
call9.005.608.806.5911.01517.003.000.978-0.0790.001
call10.004.608.606.2712.5669.004.000.975-0.0770.001
call11.003.607.605.3511.0486.006.000.938-0.1670.001
call11.503.406.704.779.0873.002.000.933-0.1630.002
call12.003.105.304.275.5474.005.000.927-0.1580.002
call12.502.155.900.006.6790.000.000.919-0.1530.002
call13.002.604.303.094.62890.003.000.911-0.1480.002
call13.502.253.802.594.18590.003.000.900-0.1420.002
call14.001.203.301.783.7480.001.000.888-0.1350.002
call14.501.352.852.063.4510.001.000.871-0.1270.002
call15.000.852.301.782.8828.001.000.849-0.1180.003
call15.500.053.000.983.6193.000.000.764-0.1560.004
call16.000.302.250.684.1039.000.000.651-0.2190.004
call16.500.350.500.600.9652.003.000.576-0.1280.005
call17.000.100.300.300.92521.005.000.497-0.3400.005
call17.500.000.200.151.05039.000.000.402-0.2620.005
call18.000.000.450.051.2561220.000.207-0.1180.004
call18.500.002.150.361.6136.000.000.199-0.1450.003
call19.000.000.750.081.85944.000.000.178-0.1570.003
call19.500.002.150.052.08831.000.000.164-0.1660.003
call20.000.001.650.052.30492.000.000.152-0.1750.003
call20.500.001.950.152.50810.000.000.142-0.1820.003
call21.000.002.150.002.7030.000.000.134-0.1890.003
call21.500.002.150.002.8830.000.000.128-0.1940.002
call22.000.002.150.053.06715.000.000.122-0.2010.002
call22.500.002.150.053.23825.000.000.117-0.2060.002
call23.000.002.150.053.40239.000.000.113-0.2100.002
call23.500.002.150.003.5540.000.000.109-0.2140.002
call24.000.002.150.103.7146.000.000.106-0.2190.002
call24.500.002.150.003.8630.000.000.103-0.2230.002
call25.000.002.150.104.00612.000.000.100-0.2270.002
call25.500.002.150.004.1380.000.000.097-0.2290.002
call26.000.001.250.004.2730.000.000.095-0.2320.002
call26.500.001.650.004.0730.000.000.076-0.1860.002
call27.000.001.050.104.54010.000.000.091-0.2400.002
call27.500.002.150.004.6550.000.000.089-0.2420.002
call28.000.002.150.004.7760.000.000.087-0.2440.002
call29.000.002.150.005.0090.000.000.084-0.2490.002
call30.000.001.700.005.2410.000.000.082-0.2550.002
call31.000.002.150.005.4530.000.000.079-0.2600.002
call32.000.002.150.005.6450.000.000.077-0.2630.002
call33.000.002.150.005.8390.000.000.075-0.2670.002
call34.000.001.500.006.0370.000.000.074-0.2720.002
call35.000.002.150.006.2050.000.000.072-0.2740.002
put7.000.000.750.006.3640.000.00-0.016-0.0810.000
put8.000.000.750.005.4720.000.00-0.019-0.0800.001
put9.000.000.750.004.6840.000.00-0.022-0.0780.001
put10.000.000.400.003.9830.000.00-0.025-0.0760.001
put11.000.000.750.004.2130.000.00-0.062-0.1650.001
put11.500.000.750.003.8560.000.00-0.067-0.1610.002
put12.000.000.750.003.5020.000.00-0.073-0.1570.002
put12.500.000.750.003.1600.000.00-0.081-0.1520.002
put13.000.000.750.002.8250.000.00-0.089-0.1470.002
put13.500.000.750.002.4980.000.00-0.100-0.1410.002
put14.000.000.450.522.1766.000.00-0.112-0.1340.002
put14.500.000.500.001.8570.000.00-0.129-0.1260.002
put15.000.000.150.101.53648.000.00-0.151-0.1160.003
put15.500.000.500.101.2127.008.00-0.236-0.1540.004
put16.000.000.150.300.8723120.00-0.349-0.2170.004
put16.500.100.400.521.03717.000.00-0.424-0.1260.005
put17.000.052.600.305.1501530.00-0.503-0.3380.005
put17.500.053.001.355.1421880.00-0.598-0.2600.005
put18.000.103.500.854.4652.000.00-0.719-0.1810.004
put18.501.253.901.203.73810.000.00-0.801-0.1430.003
put19.001.752.902.652.9013.001.00-0.822-0.1550.003
put19.501.204.900.006.5280.000.00-0.836-0.1640.003
put20.001.655.403.486.82410.000.00-0.848-0.1730.003
put20.502.155.900.007.1040.000.00-0.858-0.1800.003
put21.002.656.400.007.3710.000.00-0.866-0.1870.003
put21.503.106.900.007.6250.000.00-0.872-0.1930.002
put22.004.707.404.577.8682.000.00-0.878-0.1980.002
put22.503.907.906.208.1010.001.00-0.883-0.2030.002
put23.004.408.405.718.3251.000.00-0.887-0.2080.002
put23.504.908.900.008.5410.000.00-0.891-0.2120.002
put24.005.409.400.008.7490.000.00-0.894-0.2160.002
put24.505.909.900.008.9490.000.00-0.897-0.2200.002
put25.006.4010.400.009.1430.000.00-0.900-0.2240.002
put25.506.9010.906.909.3300.000.00-0.903-0.2270.002
put26.007.4011.409.599.5110.001.00-0.905-0.2300.002
put26.507.9011.9010.029.6870.003.00-0.907-0.2340.002
put27.008.4012.4010.489.8580.003.00-0.909-0.2370.002
put27.508.9012.900.0010.0240.000.00-0.911-0.2390.002
put28.009.4013.409.5110.1850.000.00-0.913-0.2420.002
put29.0010.4014.400.0010.4940.000.00-0.916-0.2470.002
put30.0011.4015.400.0010.7870.000.00-0.918-0.2520.002
put31.0012.4016.400.0011.0670.000.00-0.921-0.2560.002
put32.0013.4017.4014.1811.3330.000.00-0.923-0.2600.002
put33.0014.4018.4016.4811.5871.000.00-0.925-0.2640.002
put34.0015.4019.4017.4111.8311.000.00-0.926-0.2680.002
put35.0016.4020.400.0012.0640.000.00-0.928-0.2710.002

Latest SEC filings

30
FiledFormDescriptionPeriodLink
2026-11-10SCHEDULE 13GSEC
2026-11-058-KCurrent report2026-11-05SEC
2026-11-0510-QQuarterly report pursuant to Section 13 or 15(d)2026-09-30SEC
2026-09-238-KCurrent report2026-09-23SEC
2026-09-084Statement of changes in beneficial ownership of securities2026-09-04SEC
2026-09-084Statement of changes in beneficial ownership of securities2026-09-04SEC
2026-09-084Statement of changes in beneficial ownership of securities2026-09-04SEC
2026-09-084Statement of changes in beneficial ownership of securities2026-09-04SEC
2026-08-1413F-HRFurther understand that each of 13F-HR, 13F-NT, and amendments thereto are mandatory electronic filings (hardship exemption exists to submit in paper; never used to the knowledge of IM staff);2026-06-30SEC
2026-08-13SCHEDULE 13G/ASEC
2026-08-07SCHEDULE 13GSEC
2026-08-058-KCurrent report2026-08-05SEC
2026-08-0510-QQuarterly report pursuant to Section 13 or 15(d)2026-06-30SEC
2026-07-31SCHEDULE 13G/ASEC
2026-07-30SCHEDULE 13G/ASEC
2026-07-294Statement of changes in beneficial ownership of securities2026-07-28SEC
2026-07-293Initial statement of beneficial ownership of securities2026-07-28SEC
2026-07-28S-8Initial registration statement for securities to be offered to employees pursuant to employee benefit plansSEC
2026-07-278-KCurrent report2026-07-23SEC
2026-06-054Statement of changes in beneficial ownership of securities2026-06-04SEC
2026-06-054Statement of changes in beneficial ownership of securities2026-06-04SEC
2026-06-054Statement of changes in beneficial ownership of securities2026-06-04SEC
2026-06-054Statement of changes in beneficial ownership of securities2026-06-04SEC
2026-06-054Statement of changes in beneficial ownership of securities2026-06-04SEC
2026-06-054Statement of changes in beneficial ownership of securities2026-06-04SEC
2026-06-054Statement of changes in beneficial ownership of securities2026-06-04SEC
2026-06-054Statement of changes in beneficial ownership of securities2026-06-04SEC
2026-06-04S-8Initial registration statement for securities to be offered to employees pursuant to employee benefit plansSEC
2026-06-048-KCurrent report2026-06-04SEC
2026-05-1313F-HRFurther understand that each of 13F-HR, 13F-NT, and amendments thereto are mandatory electronic filings (hardship exemption exists to submit in paper; never used to the knowledge of IM staff);2026-03-31SEC

Insider activity by month

MonthBoughtBuysSoldSells
2026-110000
2026-100000
2026-090000
2026-080000
2026-070000
2026-060000
2026-050000
2026-040000
2026-0300123.21K1
2026-020000
2026-010000
2025-1200294.20K1
2025-110000

Institutional holders

Manager% owned
BlackRock, Inc.17.99%
STATE STREET CORP8.45%
VANGUARD PORTFOLIO MANAGEMENT LLC7.94%
TWO SIGMA INVESTMENTS, LP4.36%
VANGUARD CAPITAL MANAGEMENT LLC4.35%
FIRST TRUST ADVISORS LP4.14%
AQR CAPITAL MANAGEMENT LLC4.10%
GEODE CAPITAL MANAGEMENT, LLC2.54%
Erste Asset Management GmbH2.43%
MARSHALL WACE, LLP2.09%

Funds

Fund% owned
iShares Convertible Bond ETF17.64%
Calamos Market Neutral Income Fund14.21%
State Street(R) SPDR(R) Bloomberg Convertible Securities ETF12.83%
AQR Diversified Arbitrage Fund12.65%
Columbia Convertible Securities Fund8.44%
iShares Core S&P Small-Cap ETF6.03%
State Street(R) SPDR(R) S&P(R) Biotech ETF4.23%
Bancroft Fund Ltd3.79%
Ellsworth Growth & Income Fund Ltd3.69%
First Trust NYSE Arca Biotechnology Index Fund3.39%

OakChart. SRPT. Cached 15 minutes.